sulfamethoxazole has been researched along with Centriacinar Emphysema in 3 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brändli, O | 1 |
Hasenhüttl, G | 1 |
Piolino, M | 1 |
de Kalbermatten, JP | 1 |
Dobjanski, S | 1 |
Granato, D | 1 |
Schelling, JL | 1 |
1 trial available for sulfamethoxazole and Centriacinar Emphysema
Article | Year |
---|---|
[Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
Topics: Aged; Bronchitis; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Drug Resis | 1968 |
2 other studies available for sulfamethoxazole and Centriacinar Emphysema
Article | Year |
---|---|
[Status asthmaticus following administration of drugs].
Topics: Aged; Anti-Infective Agents; Asthma; Drug Combinations; Humans; Lung Diseases, Obstructive; Male; Mi | 1988 |
[Management of bronchial infections].
Topics: Asthma; Bronchial Diseases; Bronchiectasis; Bronchitis; Bronchopneumonia; Chronic Disease; Drug Comb | 1973 |